Elsevier

Vaccine

Volume 29, Supplement 4, 30 December 2011, Pages D74-D79
Vaccine

The expanded programme on immunization: A lasting legacy of smallpox eradication

https://doi.org/10.1016/j.vaccine.2012.01.080Get rights and content

Abstract

Since the mid-1970s, the widespread establishment and implementation of the Expanded Programme on Immunization (EPI) has led to remarkable achievements in controlling vaccine preventable diseases worldwide. Today, more children than ever are being reached with immunization; interruption of poliomyelitis transmission has occurred in most countries; mortality due to measles, tetanus, diphtheria and pertussis has been reduced to record low levels. In addition, increasing numbers of vaccines are being used for infants and older age persons, such as vaccines against hepatitis A and hepatitis B, Haemophilus influenzae type b, rotavirus, pneumococcus, meningococcus, human papilloma virus (HPV) and varicella.

The design of EPI reflects in large part the experience accumulated during the implementation of the intensified campaign for smallpox eradication during the period 1966–1977. At that time, the existing health infrastructure and network was found inadequate to reach most individuals with community wide immunization programmes in most countries. Thus, efforts were made to train dedicated health personnel and allocate specific resources for programme coordination and implementation. With the establishment of EPI, there was a gradual shift in emphasis from vaccination campaign strategies using mobile teams to the delivery of immunization services as part of routine health services of health facilities. Both the campaign and the outreach strategies are nevertheless required to reach those segments of the population not reached by the routine health services and to accelerate the achievement of disease control initiatives such as polio eradication and measles elimination.

Whilst the campaign for smallpox eradication was set up as special and time-limited effort, the EPI requires long-term sustainable approaches to protect new cohorts of susceptible persons with vaccination and monitor trends and progress towards disease control with high quality surveillance.

Introduction

In May 1974, the World Health Assembly (WHA) requested the World Health Organization (WHO) to establish EPI to provide universal access to a set of life-saving vaccines [1]. The immense success of the world-wide smallpox eradication programme, which was intensified from 1966 to 1977, provided the evidence that universal access with immunization was possible. This realization, together with the fact that vaccines against a number of life-threatening diseases existed but reached only a very small proportion of the populations in developing countries led to the decision to establish EPI.

Smallpox eradication benefited from dedicated financial and human resources, high level political and community support and adequate logistics systems. In many countries, smallpox teams undertook to provide other vaccines such as Bacille Calmette-Guerin (BCG), measles, yellow fever and diphtheria–tetanus–pertussis (DTP) vaccines [2]. These formed the basis for the strengthening of the broader immunization programmes in many countries.

The principles, lessons and benefits from the smallpox eradication campaign have been well documented and are referred to in the various articles contained in this supplement. Here, we focus on four of them that are relevant to EPI as a base for sustainable vaccine delivery as well as the adaptation of vaccination strategies to reach disease elimination and eradication: firstly, the definition of objectives and goals which is a key element in determining programme strategies and tactics; secondly, vaccine quality control to ensure the use of potent vaccines at all times; thirdly, the need for reliable supply systems to support field operations; and fourthly, ensuring that safe immunization practices are implemented in all countries. We also discuss some of the remaining challenges and ways forward so that the benefits of vaccines and immunization are further expanded during the next decade of vaccines and beyond.

Section snippets

Establishing objectives and goals

In 1966, the launch of the intensified smallpox eradication programme was marked with the setting of a clear ultimate objective of “nil incidence of smallpox”. Making this objective explicit served to adjust programme strategies and tactics. The performance measurement shifted from measuring the numbers of vaccinations performed to improving methods for case detection and containment of outbreaks.

Setting measurable goals is a key element that stimulates commitment for planning and allocation of

Remaining challenges and ways forward

Despite the extraordinary progress made towards reducing vaccine-preventable diseases, the immunization agenda remains largely unfinished. Whilst the estimated number of all deaths in children under five in 2008 was 8.8 million, nearly 20% of all deaths in children under 5 are vaccine preventable [24]. The total number of children who died from diseases preventable by vaccines currently recommended by WHO is approximately 1.7 million.3

Conclusions

During the past four decades, the world achieved unprecedented gains with the use of vaccines in saving lives, building from the lessons and experience of the smallpox eradication programme, including strong political commitment at global level, national leadership and coordination, effective programme management, vaccine quality control, performance monitoring and innovation.

Despite the challenges of limited health system capacity and competing priorities in several low income countries,

Conflict of interest

None.

References (27)

  • L. Brestlow

    RulesSetting objectives for public health

    Am Rev Public Health

    (1987)
  • World Health Organization

    Global routine vaccination coverage, 2010

    Weekly Epidemiologic Rec

    (2011)
  • R.H. Henderson et al.

    Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method

    Bull World Health Organ

    (1982)
  • Cited by (0)

    View full text